GDNF (glial cell derived neurotrophic factor)

2003-02-01  

Identity

HGNC
LOCATION
5p13.2
LOCUSID
ALIAS
ATF,ATF1,ATF2,HFB1-GDNF,HSCR3
FUSION GENES

Other Information

Locus ID:

NCBI: 2668
MIM: 600837
HGNC: 4232
Ensembl: ENSG00000168621

Variants:

dbSNP: 2668
ClinVar: 2668
TCGA: ENSG00000168621
COSMIC: GDNF

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000168621ENST00000326524P39905
ENSG00000168621ENST00000326524A0A0S2Z3V2
ENSG00000168621ENST00000344622P39905
ENSG00000168621ENST00000344622A0A0S2Z3T2
ENSG00000168621ENST00000381826P39905
ENSG00000168621ENST00000427982P39905
ENSG00000168621ENST00000502572A0A0C4DGC2
ENSG00000168621ENST00000510177A0A0C4DGC2
ENSG00000168621ENST00000515058P39905
ENSG00000168621ENST00000515058A0A0S2Z3T2
ENSG00000168621ENST00000620847P39905

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
Immune SystemREACTOMER-HSA-168256
Innate Immune SystemREACTOMER-HSA-168249
DAP12 interactionsREACTOMER-HSA-2172127
DAP12 signalingREACTOMER-HSA-2424491
RAF/MAP kinase cascadeREACTOMER-HSA-5673001
Fc epsilon receptor (FCERI) signalingREACTOMER-HSA-2454202
FCERI mediated MAPK activationREACTOMER-HSA-2871796
Cytokine Signaling in Immune systemREACTOMER-HSA-1280215
Signaling by InterleukinsREACTOMER-HSA-449147
Interleukin-2 signalingREACTOMER-HSA-451927
Interleukin receptor SHC signalingREACTOMER-HSA-912526
Interleukin-3, 5 and GM-CSF signalingREACTOMER-HSA-512988
Signal TransductionREACTOMER-HSA-162582
Signaling by EGFRREACTOMER-HSA-177929
GRB2 events in EGFR signalingREACTOMER-HSA-179812
SHC1 events in EGFR signalingREACTOMER-HSA-180336
Signaling by Insulin receptorREACTOMER-HSA-74752
Insulin receptor signalling cascadeREACTOMER-HSA-74751
IRS-mediated signallingREACTOMER-HSA-112399
SOS-mediated signallingREACTOMER-HSA-112412
Signalling by NGFREACTOMER-HSA-166520
NGF signalling via TRKA from the plasma membraneREACTOMER-HSA-187037
Signalling to ERKsREACTOMER-HSA-187687
Signalling to RASREACTOMER-HSA-167044
Signalling to p38 via RIT and RINREACTOMER-HSA-187706
Prolonged ERK activation eventsREACTOMER-HSA-169893
Frs2-mediated activationREACTOMER-HSA-170968
ARMS-mediated activationREACTOMER-HSA-170984
Signaling by PDGFREACTOMER-HSA-186797
Downstream signal transductionREACTOMER-HSA-186763
Signaling by VEGFREACTOMER-HSA-194138
VEGFA-VEGFR2 PathwayREACTOMER-HSA-4420097
VEGFR2 mediated cell proliferationREACTOMER-HSA-5218921
Signaling by SCF-KITREACTOMER-HSA-1433557
MAPK family signaling cascadesREACTOMER-HSA-5683057
MAPK1/MAPK3 signalingREACTOMER-HSA-5684996
Signaling by GPCRREACTOMER-HSA-372790
Gastrin-CREB signalling pathway via PKC and MAPKREACTOMER-HSA-881907
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)REACTOMER-HSA-2404192
IGF1R signaling cascadeREACTOMER-HSA-2428924
IRS-related events triggered by IGF1RREACTOMER-HSA-2428928
Signaling by LeptinREACTOMER-HSA-2586552
Developmental BiologyREACTOMER-HSA-1266738
Axon guidanceREACTOMER-HSA-422475
NCAM signaling for neurite out-growthREACTOMER-HSA-375165
NCAM1 interactionsREACTOMER-HSA-419037
RET signalingREACTOMER-HSA-8853659

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA447321Depressive Disorder, MajorDiseaseClinicalAnnotationassociatedPD24577123
PA450801paroxetineChemicalClinicalAnnotationassociatedPD24577123

References

Pubmed IDYearTitleCitations
377185942024Distinct serum GDNF coupling with brain structural and functional changes underlies cognitive status in Parkinson's disease.1
378585112024Plasma GDNF levels in spinal dysraphism and its relation with neurological impairment in children: A point of care study.0
383079472024The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy.2
386740632024MicroRNA-Mediated Suppression of Glial Cell Line-Derived Neurotrophic Factor Expression Is Modulated by a Schizophrenia-Associated Non-Coding Polymorphism.0
377185942024Distinct serum GDNF coupling with brain structural and functional changes underlies cognitive status in Parkinson's disease.1
378585112024Plasma GDNF levels in spinal dysraphism and its relation with neurological impairment in children: A point of care study.0
383079472024The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy.2
386740632024MicroRNA-Mediated Suppression of Glial Cell Line-Derived Neurotrophic Factor Expression Is Modulated by a Schizophrenia-Associated Non-Coding Polymorphism.0
367652752023GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1.2
370616182023High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer.1
374103162023Finding an Optimal Level of GDNF Overexpression: Insights from Dopamine Cycling.0
377863472023Human Neural Progenitors Expressing GDNF Enhance Retinal Protection in a Rodent Model of Retinal Degeneration.1
380691442023Reduced Levels of Lacrimal Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Patients with Focal Epilepsy and Focal Epilepsy with Comorbid Depression: A Biomarker Candidate.0
367652752023GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1.2
370616182023High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer.1

Citation

Dessen P

GDNF (glial cell derived neurotrophic factor)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/40705/img/favicon/tumors-explorer/